SurgoCap Partners’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295M Buy
7,487,507
+1,412,342
+23% +$56.9M 9.55% 5
2026
Q1
$270M Buy
+6,075,165
New +$268M 9.03% 6

Other funds holding MDLN

SurgoCap Partners's MDLN Position: Q2 2026 in Review

SurgoCap Partners increased its Medline Inc (MDLN) stake by 23% in Q2 2026, buying an estimated $56.9M and bringing the position to 7,487,507 shares worth $295M. The position accounts for 9.55% of the portfolio, ranked #5.

SurgoCap Partners first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • SurgoCap Partners held 7,487,507 shares of Medline Inc worth $295M as of Q2 2026.
  • SurgoCap Partners bought 1,412,342 Medline Inc shares in Q2 2026, an estimated $56.9M.
  • Medline Inc made up 9.55% of SurgoCap Partners's portfolio in Q2 2026, its #5 holding.
  • SurgoCap Partners first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on SurgoCap Partners's 13F filing for Q2 2026, filed 14 Aug 2026.